EcoSynthetix (ECO) Q1 2025 earnings summary

Executive summary

• Q1 2025 net sales declined 14% year-over-year to CAD 4 million ($4.0 million), driven by broad-based demand softness, prior inventory buildup, and global uncertainty.

• Adjusted EBITDA loss was CAD 500,000 ($0.5 million), flat year-over-year, with cash generation and liquidity remaining strong.

• Strategic accounts in pulp, wood composites, and tissue maintained steady orders, advanced operational initiatives, and signaled long-term commitment to biopolymer adoption.

• Significant progress in commercializing SurfLock™ strength aids, including a CAD 1.1 million order from a global pulp leader and expanded use at tissue customers.

• Personal care segment, in partnership with Dow, expanded all-natural polymer applications and is expected to contribute further growth in 2025.

Financial highlights

• Net sales were CAD 4 million ($4.0 million) in Q1 2025, down 14% year-over-year, mainly due to a 12% drop in volumes and prior distributor inventory buildup.

• Gross profit was CAD 870,000 ($0.9 million), with gross margin at 21.5% (27.2% adjusted, excluding depreciation), both down from the prior year.

• SG&A expenses improved 15% to CAD 1.5 million ($1.5 million), reflecting lower asset relocation costs.

• R&D expenses remained stable at CAD 380,000 ($0.4 million), representing 10% of sales.

• Cash and term deposits stood at CAD 31.4 million ($31.4 million) as of March 31, 2025.

Outlook and guidance

• Management remains confident in long-term growth, citing a CAD 60 million+ opportunity in pulp and CAD 50 million+ in wood composites by 2028 and 2030, respectively.

• Focus remains on growing with key strategic accounts in tissue, pulp, paperboard, wood composites, and personal care, with commercial momentum anticipated in the back half of 2025.

• Ongoing investment in R&D (~CAD 2 million/year) to maintain competitive advantage and support growth.